健全的科技创造突破性产品

我们的科技

Max致力于制造、提供促进人体谷胱甘肽含量的最佳产品到全世界,我们都知道高品质保健产品一定要经过科学研究验证,这是极为重要的。Max International决心要成为营养保健食品业的龙头,提供经科学证实具有高品质独特配方的产品,帮助人体制造最重要的抗氧化剂–谷胱甘肽。目前已有超过十万篇有关谷胱甘肽及其好处的同侪审查报告刊登于PubMed.com这个数字甚至是维他命C的两倍之多。

不断地坚持与无数实验,终于开发出RiboCeine。对我来说这是皇天不负苦心人的一刻。

感谢药物化学家赫伯特‧永泽博士 (Dr. Herbert T. Nagasawa) 以及其他专家在科技研发方面所做的努力,让Max International在提升谷胱甘肽的营养食品上有着突破性的先进技术。目前已有超过23篇经过同侪审查的论文是以他们的专利化合物RiboCeine为研究主题。

有关核糖–半胱氨酸 (Ribose-Cysteine) 之影响的独立研究

注意:下列连结将会带您离开本网页,并前往第三方研究网站。

1.Saltman A.E.D-ribose-L-cysteine supplementation enhances wound healing in a rodent model.Am J Surg.2015, 210, 153-158.

2.Kader, T.; Porteous C.M.; Williams M.A.J.A.; Gieseg, S.P.; McCormick, S.P.A.Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice.Atherosclerosis.2014, 237, 725-733.

3.Jurkowska, H.; Uchacz, T.; Roberts, J.; Wrobel, M.Potential therapeutic advantage of ribose-cysteine in the inhibition of astrocytoma cell proliferation.Amino Acids,2011, 41, 131-139.

4.Heman-Ackah, S.E.; Juhn, S.K.; Huang, T.C.; Wiedmann, T.S.A combination antioxidant therapy prevents age-related hearing loss in C57BL/6 mice.Otolaryngology-Head and Neck Surgery, 2010,143, 429-434.

5.Oz, H.S.; Chen, T.S.; Nagasawa, H.,Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model.Translational Research,, 150(2), 122-129., 150(2), 122-129.

6.Lucas Slitt, A.M.; Dominick, P.K.; Roberts, J.C.; Cohen, S.D.Effect of Ribose Cysteine Pretreatment on Hepatic and Renal Acetaminophen Metabolite Formation and Glutathione Depletion.Basic Clin. Pharmacol. Toxicol.,2005, 96 (6), 487-94.

7.Waldron, C.A.; Vannais, D.B.; Ueno A.M.A role for long-lived radicals (LLR) in radiation-induced mutation and persistent chromosomal instability: counteraction by Ascorbate and RibCys but not DMSO.Mutation Research.2004, 551, 255-265.

8.Lenarczyk, M.; Ueno, A.; Vannais, D.B.; Kraemer, S.; Kronenberg, A.; Roberts, J.C.; Tatsumi, K.; Hei, T.K.; Waldron, C.A.The "Pro-drug" RibCys Decreases the Mutagenicity of High-LET Radiation in Cultured Mammalian Cells. Radiation Research,2003, 160, 579-583.

9.Wilmore, B.H.; Cassidy, P.B.; Warters, R.L.; Roberts, J.C.Thiazolidine Prodrugs as Protective Agents against y-Radiation-Induced Toxicity and Mutagenesis in V79 Cells.J. Med. Chem.,, 44(16), 2661-2666., 44(16), 2661-2666.

10.Lucus, A.M.; Henning G.; Dominick, P.K.; Whiteley, H.E.; Roberts, J.C.; Cohen, S.D.Ribose Cysteine Protects Against Acetaminophen-Induced Hepatic and Renal Toxicity.Toxicologic Pathology,2000, 28(5), 697-704.

11.Roberts, J.C.; Phaneuf, H.L.; Dominick, P.K.; Wilmore, B.H.; Cassidy, P.B.Biodistribution of [35S] - Cysteine and Cysteine Prodrugs: Potential Impact on Chemoprotection Strategies.J. Labelled Cpd. Radiopharm.,1999all.riboceine.study1.51

12.Roberts, J.C.; Phaneuf, H.L.; Szakacs, J.G.; Zera, R.T.; Lamb, J.G.; Franklin, M.R.Differential Chemoprotection against Acetaminophen-Induced Hepatotoxicity by Latentiated L-Cysteines.Chem. Res. Toxicol.,1998, 11, 1274-1282.

13.Bantseev, V.; Bhardwaj, R.; Rathbun, W.; Nagasawa, H.T.; Trevithick, J.R.Antioxidants and Cataract: (Cataract Induction in Space Environment and Application to Terrestrial Aging Cataract).Biochem. Mol. Bio. Intl.,1997, 42, 1189-1197.

Roberts, J.C.; Koch, K.E.; Detrick, S.R.; Warters, R.L.; Lubec G.14.Thiazolidine Prodrugs of Cysteamine and Cysteine as Radioprotective Agents.Radiation Research,1995, 143, 203-213.

15.Carroll, M.P.; Zera, R.T.; Roberts, J.C.; Schlafmann, S.E.; Feeny, D.A.; Johnston, G.R.; West, M.A.; Bubrick, M.P.Efficacy of Radioprotective Agents in Preventing Small and Large Bowel Radiation Injury.Dis. Colon Rectum,1995, 38(7), 716-722.

16.Roberts, J.C.;Francetic, D.J.; Zera, R.T.Chemoprotection against Cyclophosphamide-Induced Urotoxicity: Comparison of Nine Thiol Protective Agents.AntiCancer Research,1994, 14, 389-396.

17.Rowe, J.K.; Zera, R.T.; Madoff, R.D.; Fink, A.S.; Roberts, J.C.; Johnston, G.R.; Freeney, D.A.;Young, H.L.; Bubrick, M.P.Protective Effect of RibCys Following High-Dose Irradiation of the Rectosigmoid.Dis. Colon Rectum,1993, 36(7), 681-687.

18.Roberts, J.C.; Charyulu, R. L.; Zera, R.T.; Nagasawa, H.T.Protection Against Acetaminophen Hepatotoxicity by Ribose-Cysteine (RibCys).Pharmacology & Toxicology,1992, 70, 281-285.

19.Roberts, J.C.; Francetic, D.J.Mechanisms of Chemoprotection by RibCys, a Thiazolidine Prodrug of L-cysteine.Med. Chem. Res.,1991, 1, 213-219.

20.Roberts, J.C.; Francetic, D.J.Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys.Toxicology Letters,1991, 59, 245-251.

21.Roberts, J.C.; Francetic, D.J.; Zera, R.T.L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.Cancer Chemotherapy and Pharmacology,1991, 28, 166-170.

22.Roberts, J.C.; Nagasawa, H.T.; Zera, R.T.; Fricke, R.F.; Goon, D.J.W.Prodrugs of L-Cysteine as Protective Agents against Acetaminophen-Induced Hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(Polyacetoxyalkyl)thiazolidine-4(R)-carboxylic Acids.. J. Med. Chem.,1987, 30, 1891-1896.

请自订您的销售地区及语言偏好

地区/地区

cross-img
  • Submit
shadow